University of Queensland researchers have produced batches of a monoclonal antibody, which may offer hope as a potential therapeutic for Hendra virus infection in humans. The batches have been developed in UQ's Australian Institute for Bioengineering and Nanotechnology (AIBN). US Hendra virus...